Cognizant Technology Lowers FY22 Outlook

While reporting its results for the first quarter on Wednesday, tech company Cognizant Technology Solutions Corporation (CTSH) lowered its outlook for the full year 2022.

Looking forward, the company expects revenue to be $19.8 billion to $20.2 billion, or growth of 7.2%-9.2%, and adjusted earnings of $$4.45 to $4.55 per share.

Previously, the company expected full-year revenues $20.0 billion to $20.5 billion and adjusted earnings of $4.46 to $4.60 per share.

Analysts polled by Thomson Reuters currently expect earnings of $4.56 per share and revenues of $20.22 billion. Analysts' estimates typically exclude one-time items.

Cognizant Chief Financial Officer Jan Siegmund said, "Our updated 2022 constant currency revenue guidance includes an improved organic revenue growth outlook and a lower inorganic contribution, reflecting a disciplined acquisition strategy."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Hormel Foods Corp. (HRL) said, in the fourth quarter, the company delivered earnings per share comparable with record results last year, which included an additional week of sales. Pretax earnings were $357 million, up 1% from a year ago. Organic net sales were up 2%, excluding the impact of an additional... Over the Thanksgiving holiday weekend, from Thanksgiving Day to Cyber Monday, around 196.7 million Americans shopped in stores and online, higher than the previous year, according to the National Retail Federation or NRF. Black Friday continued to be the most favored day for in-store as well as online shopping during the five-day holiday period. Lenoir, North Carolina -based Exela Pharma Sciences, LLC has expanded its recall of Sodium Bicarbonate Injection due to vial breakage to include more lots, the U.S. Food and Drug Administration said. The product is used for treatment of metabolic acidosis and is packaged in a 50 mL glass vial, 20 vials per carton.
Follow RTT